Austin Business Journal by Christopher Calnan
Venture capital firm Santé Ventures has received $133.8 million of a planned $150 million round of funding.
The Austin-based company collected the capital from 15 investors, according to a Tuesday filing with the U.S. Securities and Exchange Commission.
Santé, founded in 2006, invests exclusively in early-stage companies developing medical technologies or health care delivery models. In 2007, the firm closed its debut fund at $130 million.
In March, it reported receiving $91.6 million from 13 investors.
Santé Ventures’ portfolio companies include BioStable Science & Engineering Inc., an Austin-based medical device company developing cardiovascular implants, and biopharmaceutical company Terapio Corp.
In 2009, Austin-based Terapio closed on a $5 million Series A round of financing. In 2008, BioStable Science completed a $5.5 million Series A round of funding.